Several studies have reported an increased risk of mortality among children hospitalised with multiple infections (including respiratory signs and symptoms) 21 and the presence of multiple conditions reported among children who died in hospital settings despite cause of death being assigned to one disease.
Effects are multiplicative, meaning that, for example if we compare two women with normal cytology, one woman who is aged 20 and has no HPV-16 infection, the other woman who is 30 and has multiple infections including HPV-16, this latter woman has a 415% increased risk of having an HR-HPV infection at follow-up.
Multiple infections include the association with hr and/or lr-HPV types.
The most prevalent HPV types were 16, 51, 31, 52 and 18, and the most common HPV types detected in multiple infections included 16, 51, 18, 31 and 52.
Multiple nosocomial infections including pneumonia (n = 92) or non-intubated patients with NP (n = 3) were excluded from the study.
This model has already been established for multiple streptococcal infections, including Streptococcus pyogenes [ 31], Streptococcus pneumonia [ 31], Streptococcus suis [ 32] and Streptococcus agalactiae [ 33].
Multiple nosocomial infections including pneumonia and NP in non-intubated patients were excluded from the study because we aimed to detect independent risk factors and the costs, for only VAP.
A total of 3,150 HPV infections, including multiple infections, were identified among the 2,902 cases.
Vaccines against multiple other stillbirth-causing infections, including herpes viruses (HSV 1 and 2), cytomegalovirus, other microorganisms including group B Streptococcus, Leptospira, the agents of Q fever and malaria, and common sexually transmitted infections as well as Ebola and human parvovirus (HPV-B19), may hold considerable promise if they become available [ 12, 13].
Exclusion criteria were preterm deliveries, multiple gestation (twins, triplets), perinatal infections including fever around birth, maternal intake of medication and maternal chronic diseases.
Review of MRS studies in multiple sclerosis (MS) and neuroviral infections including HIV and hepatitis C (HCV) suggests that neuroinflammation is associated with elevated levels of myo-inositol (mI), choline-containing compounds (Cho) and total creatine (tCr) (22), whereas neuronal injury (dysfunction or loss) is associated with low levels of N-acetyl aspartate (NAA) and glutamate (Glu) (22).
